Connor, Clark & Lunn Investment Management Ltd. Novartis Ag Transaction History
Connor, Clark & Lunn Investment Management Ltd.
- $18.8 Billion
- Q3 2024
A detailed history of Connor, Clark & Lunn Investment Management Ltd. transactions in Novartis Ag stock. As of the latest transaction made, Connor, Clark & Lunn Investment Management Ltd. holds 191,317 shares of NVS stock, worth $19.9 Million. This represents 0.12% of its overall portfolio holdings.
Number of Shares
191,317
Previous 78,057
145.1%
Holding current value
$19.9 Million
Previous $8.31 Million
164.83%
% of portfolio
0.12%
Previous 0.04%
Shares
24 transactions
Others Institutions Holding NVS
# of Institutions
1,437Shares Held
133MCall Options Held
1.12MPut Options Held
1.83M-
Dodge & Cox San Francisco, CA12.2MShares$1.27 Billion0.85% of portfolio
-
Primecap Management CO Pasadena, CA12MShares$1.25 Billion1.03% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.09MShares$840 Million0.23% of portfolio
-
Morgan Stanley New York, NY6.98MShares$725 Million0.06% of portfolio
-
Loomis Sayles & CO L P5.77MShares$599 Million0.87% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $223B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...